Skip to main content
OpenTrials

Clinical trial condition

Colorectal Neoplasms

Explore clinical trials studying Colorectal Neoplasms. Study availability and eligibility vary by location and protocol.

4,329 public trials 916 recruiting studies
Refine in advanced search Browse all conditions

Colorectal Neoplasms trial results

Recruiting

Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors

NCT07349537

Conditions
Advanced Solid Tumors, Bronchial Neoplasms, CRC, +30 more
Locations
  • Yale Cancer Center New Haven, Connecticut, United States
  • Johns Hopkins Baltimore, Maryland, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • START Midwest Grand Rapids, Michigan, United States
View Trial Details
Recruiting

A Phase 1 Study of IM-1617 in Participants With Advanced Cancer

NCT07578571

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +31 more
Locations
  • Florida Cancer Specialists & Research Institute - Sarasota Cattlemen Sarasota, Florida, United States
  • NEXT Dallas Irving, Texas, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Yale Cancer Center New Haven, Connecticut, United States
View Trial Details
Recruiting

Tislelizumab in People With Colorectal Cancer

NCT06529523

Conditions
Colonic Diseases, Colorectal Cancer, Colorectal Neoplasms, +9 more
Locations
  • Memorial Sloan Kettering Cancer Center New York, United States
  • Obafemi Awolowo University Teaching Hospital Ile-Ife, Nigeria
  • Lagos University Teaching Hospital Idi-Araba, Lagos, Nigeria
View Trial Details
Recruiting

Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies

NCT05786924

Conditions
Acquired Resistance to KRAS G12C Inhibitor, BRAF, BRAF Gene Mutation, +61 more
Locations
  • Banner Health- MD Anderson Cancer Center Gilbert, Arizona, United States
  • The Angeles clinic - A cedars SINAI AFFILIATE Los Angeles, California, United States
  • USC Norris Comprehensive Cancer Center Los Angeles, California, United States
  • University of California, San Francisco (UCSF) San Francisco, California, United States
View all 49 locations
View Trial Details
Recruiting

Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread

NCT06324357

Conditions
Adenocarcinoma Of Esophagus, Breast Diseases, Breast Neoplasms, +18 more
Locations
  • The Oncology Institute of Hope and Innovation Cerritos, California, United States
  • Ellison Medical Institute Los Angeles, California, United States
  • Valkyrie Clinical Trials Los Angeles, California, United States
  • University of California Los Angeles Los Angeles, California, United States
View all 105 locations
View Trial Details

Related conditions